Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon Genetics Reports Q2 Revenue Upswing, Reduced Losses

SAN FRANCISCO, Aug. 7 - Lexicon Genetics today reported an increase in second quarter revenue and a decrease in net loss.


For the three months ended June 30, Lexicon reported total revenues of $9.4 million compared with $3.5 million for the same period one year ago. Revenue for the quarter included $5 million in subscription and license fees and $4.3 million from collaborative research agreements, according to the company.


Net loss for the quarter decreased to $14.9 million, or $.29 per share, compared to $9.9 million, or $.20 per share, for the year-ago period.


R&D spending rose to approximately $19 million from $10.7 million for the second quarter in 2001


The company said it had roughly $135.1 million in cash and investments as of June 30.


Click here for more information.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.